Browse > Article
http://dx.doi.org/10.3347/kjp.2014.52.6.621

Prevalence and Clinical Manifestations of Malaria in Aligarh, India  

Asma, Umm-E (Department of Zoology, Aligarh Muslim University)
Taufiq, Farha (Department of Zoology, Aligarh Muslim University)
Khan, Wajihullah (Department of Zoology, Aligarh Muslim University)
Publication Information
Parasites, Hosts and Diseases / v.52, no.6, 2014 , pp. 621-629 More about this Journal
Abstract
Malaria is one of the most widespread infectious diseases of tropical countries with an estimated 207 million cases globally. In India, there are endemic pockets of this disease, including Aligarh. Hundreds of Plasmodium falciparum and P. vivax cases with severe pathological conditions are recorded every year in this district. The aim of this study is to find out changes in liver enzymes and kidney markers. Specific diagnosis for P. falciparum and P. vivax was made by microscopic examination of Giemsa stained slides. Clinical symptoms were observed in both of these infections. Liver enzymes, such as AST, ALT, and ALP, and kidney function markers, such as creatinine and urea, were estimated by standard biochemical techniques. In Aligarh district, P. vivax, P. falciparum, and mixed infections were 64%, 34%, and 2%, respectively. In case of P. falciparum infection, the incidences of anemia, splenomegaly, renal failure, jaundice, and neurological sequelae were higher compared to those in P. vivax infection. Recrudescence and relapse rates were 18% and 20% in P. falciparum and P. vivax infections, respectively. Liver dysfunctions and renal failures were more common in P. falciparum patients, particularly in elderly patients. Artesunate derivatives must, therefore, be introduced for the treatment of P. falciparum as they resist to chloroquine as well as sulfadoxine-pyrimethamine combinations.
Keywords
Plasmodium falciparum; Plasmodium vivax; malaria; prevalence; clinical features; Aligarh; India;
Citations & Related Records
연도 인용수 순위
  • Reference
1 World Health Organization. 2013 (http://who.int/malaria/publications/world_malaria_report_2013/en).
2 Quintero JP, Siqueira AM, Tobon A, Blair S, Moreno A. Arevalo-Herrera M, Lacerda M V, Valencia SH. Malaria-related anemia: a Latin American perspective. Mems Inst Oswaldo Cruz 2011; 106 (suppl. 1): 91-104.   DOI
3 Dicko A, Mantel C, Thera MA, Doumbia S, Diallo M, Diakite M, Sagara I, Doumbo OK. Risk factor of malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop 2003; 89: 17-23.   DOI
4 Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R. Indicators of life-threatening malaria in African children. New Engl J Med 1995; 332: 1399-1404.   DOI
5 Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J, Crawley J, Fegan G, Bauni E, Peshu N, Marsh K, Neville B, Newton C. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA 2007; 297: 2232-2240.   DOI
6 Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, O'Brien C, Bassat Q, Lacerda MVG. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One 2012; 7: e35406.   DOI
7 Sharma A, Khanduri U. How benign is benign tertian malaria? J Vect Borne Dis 2009; 46: 141-144.
8 Singh H, Parakh A, Basu S, Rath B. Plasmodium vivax malaria: is it actually benign? J Infect Public Health 2011; 4: 91-95.   DOI
9 Limaye CS, Londhey VA, Nabar ST. The study of complications of vivax malaria in comparision with falciparum malaria in Mumbai. J Assoc Physicians India 2012; 60: 15-18.
10 Adak T, Sharma VP, Orlov VS. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Am J Trop Med Hyg 1998; 59: 175-179.   DOI
11 World Health Organization Roll Back Malaria Department and United Nations Children's fund. World Malaria Report, 2005 (www.paho.org/English/AD/DPC/CD/mal-world-rpt-2005.htm).
12 Wilkinson JH, Baron DN, Moss DW, Walker PG. Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases. J Clin Pathol 1972; 25: 940-944.   DOI
13 Burtis CA, Ashwood ER. Textbook of Clinical Chemistry. Philadelphia, USA. Saunders Company. 1999, pp. 616-721.
14 Thomas L, Whicher JT, Andert SE. Clinical Laboratory Diagnostics. Frankfurt, Germany. TH-Books Verlagsges-ellschaft. 1998, pp. 366-374.
15 Rizvi I, Tripathi DK, Chughtai AM, Beg M, Zaman S, Zaidi N. Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India. Ann Afr Med 2013; 12: 155-159.   DOI
16 Kaplan A. Standard Methods of Clinical Chemistry. New York, USA. Academic Press. 1965, pp. 245-256.
17 Gupta NK, Bansal SB, Jain UC, Sahare K. Study of thrombocytopenia in patients of malaria. Trop Parasitol 2013; 3: 58-61.   DOI
18 Joshi H, Prajapati SK, Verma A, Kang'a S, Carlton JM. Plasmodium vivax in India. Trends Parasitol 2008; 24: 228-235.   DOI
19 Ghosh SK, Yadav RS, Sharma VP. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa. Indian J Malariol 1992; 29: 211-218.
20 Rasheed A, Saeed S, Khan SA. Clinical and laboratory findings in acute malaria cases by various Plasmodium species. J Pakistan Med Assoc 2009; 54: 220-223.
21 Banzal S, Ayoola FA, El Sammani FE, Rahim SI, Subramanium P, Gadour MOE, Jain AK. The clinical pattern and complications of severe malaria in the Jazan region of Saudi Arabia. Ann Saudi Med 1999; 1: 378-380.
22 Muddaiah M, Prakash PS. A study of clinical profile of malaria in a tertiary referral centre in South Canara. J Vect Borne Dis 2006; 43: 29-33.
23 Jadhav UM, Patkar VS, Kadam NN. Thrombocytopenia in malaria-correlated with type and severity of malaria. J Assoc Physicians India 2004; 52: 615-618.
24 Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price NR. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 2008; 5: e128.   DOI   ScienceOn
25 Daily JP, Scanfeld D, Pochet N, Le Roch K, Plouffe D, Kamal M, Sarr O, Mboup S, Ndir O, Wypij D, Levasseur K, Thomas E, Tamayo P, Dong C, Zhou Y, Lander ES, Ndiaye D, Wirth D, Winzeler EA, Mesirov JP, Regev A. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 2007; 450: 1091-1095.   DOI
26 Kochar DK, Kaswan K, Kochar SK, Sirohi P, Pal M, Kochar A, Agrawal RP, Das A. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis. J Vect Borne Dis 2006; 43: 123-129.
27 Brattig NW, Kowalsky K, Liu X, Burchard GD, Kamena F, Seeberger PH. Plasmodium falciparum glycosylphosphatidylinositol toxin interacts with the membrane of non-parasitized red blood cells: a putative mechanism contributing to malaria anemia. Microbes Infect 2008; 10: 885-891.   DOI
28 Bashawri LA, Mandil AA, Bahnassy AA, Al-Shamsi MA, Bukhari HA. Epidemiological profile of malaria in a university hospital in eastern region of Saudi Arabia. Saudi Med J 2001; 22: 133-138.
29 Malik GM, Seidi O, El-Taher AM, Mohammad AS. Clinical aspects of malaria in the Asir region, Saudi Arabia. Ann Saudi Med 1998; 18: 15-17.   DOI
30 Joseph V, Verma M, Vidhyasagar S, Mathew A. Comparison of clinical profile and complications of mixed malarial infections of Plasmodium falciparum and Plasmodium vivax versus Plasmodium falciparum mono-infection. Sultan Qaboos Univ Med J 2011; 11: 377-382.
31 Tripathy R, Parida S, Das L, Mishra DP, Tripathy D, Das MC, Chen H, Maguire JH, Panigrahi P. Clinical manifestations and predictors of severe malaria in Indian children. Pediatrics 2007; 120: e454-e460.   DOI
32 Hazra BR, Chowdhury RS, Saha SK, Ghosh MB, Mazumder AK. Changing scenario of malaria: a study at Calcutta. Indian J Malariol 1998; 35: 111-116.
33 Onyesom I, Onyemakonor N. Level of parasitaemia and changes in some liver enzymes among malarial infected patients in Edo-Delta region of Nigeria. Curr Res J Biol Sci 2011; 3: 78-81.
34 Anvikar AR, Singh DK, Singh R, Das AP, Valecha N. Vivax malaria presenting with cerebral malaria and convulsions. Acta Parasitol 2010; 55: 96-98.
35 Manan JA, Ali H, Lal M. Acute renal failure associated with malaria. J Ayub Med Coll Abbottabad 2006; 18: 47-52.
36 Vannaphan S, Walters N, Saengnedsawang T, Tangpukdee N, Kham-In P, Klubprasit M, Wilairatana P, Looareesuwan S. Factors associated with acute renal failure in severe falciparum malaria patients. Southeast Asian J Trop Med Public Health 2010; 41: 1042-1047.
37 Prakash J, Singh AK, Kumar NS, Saxena RK. Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India 2003; 51: 265-267.
38 Naqvi R, Ahmad E, Akhtar F, Naqvi A, Rizvi A. Outcome in severe acute renal failure associated with malaria. Nephrol Dial Transplant 2003; 18: 1820-1823.   DOI
39 Maheshwari A, Singh AK, Sinha DK, Tripathy K, Prakash J. Spectrum of renal disease in malaria. J Indian Med Assoc 2004; 102: 143-146.
40 Mehta KS, Halankar AR, Makwana PD, Torane PP, Satija PS, Shah VB. Severe acute renal failure in malaria. J Postgrad Med 2001; 47: 24-26.
41 Das BS. Renal failure in malaria. J Vector Borne Dis 2008; 45: 83-97.
42 Giha HA, Elghazali G, A-Elgadir TM, A-Elbasit IE, Eltahir EM, Baraka OZ, Khier MM, Adam I, Troye-Blomberg M, Theander TG, Elbashir MI. Clinical pattern of severe Plasmodium falciparum malaria in Sudan in an area characterized by seasonal and unstable malaria transmission. Trans R Soc Trop Med Hyg 2005; 99: 243-251.   DOI
43 Thanachachartwet V, Desacorn V, Sahassananda D, Win KYKK, Supaporn T. Acute renal failure in patients with severe falciparum malaria: using the WHO 2006 and RIFLE criteria. Int J Nephrol 2013; Article ID 841518, 6 pages (http://dx.doi.org/10.11559/ 2013/841518).